Category Health/Medical

Microbeads to Combat Infection show promise in Burn Wound simulations

Diagrams showing the burn wound geometry (left) and a cartoon representation of the mathematical model (right). Host cells are covered by a liquid layer known as the exudate, which is itself covered by dead (necrotic) tissue, except in the region of the excision where the exudate is exposed to the air. Bacteria and inhibitors exist in one of two states: free in the exudate or bound to the host cells, and can transition between these states by binding to and unbinding from the host cells. Both free and bound bacteria can divide; daughters of free bacteria enter the exudate, whereas some of the bound bacterial daughters remain bound to the surface, the rest entering the exudate. Bound bacteria may be consumed and destroyed (phagocytosed) by immune cells called neutrophils, while free bacteria and inhibitors may leak out of the wound (clearance) in the first twenty-four hours after the excision is made and before a scab forms over the exposed exudate. Credit: Image created by Dr. Paul A. Roberts. CC-BY

Diagrams showing the burn wound geometry (left) and a cartoon representation of the mathematical model (right). Host cells are covered by a liquid layer known as the exudate, which is itself covered by dead (necrotic) tissue, except in the region of the excision where the exudate is exposed to the air. Bacteria and inhibitors exist in one of two states: free in the exudate or bound to the host cells, and can transition between these states by binding to and unbinding from the host cells. Both free and bound bacteria can divide; daughters of free bacteria enter the exudate, whereas some of the bound bacterial daughters remain bound to the surface, the rest entering the exudate...

Read More

Bacteria Therapy for Eczema shows promise

A scientist demonstrates application of the experimental therapy to the inner elbow. For demonstration purposes, the bacteria solution has been replaced with purple dye. Credit: NIAID

A scientist demonstrates application of the experimental therapy to the inner elbow. For demonstration purposes, the bacteria solution has been replaced with purple dye. Credit: NIAID

Topical treatment with live Roseomonas mucosa – a bacterium naturally present on the skin – was safe for adults and children with atopic dermatitis (eczema) and was associated with reduced disease severity, according to initial findings from an ongoing early-phase clinical trial at the National Institutes of Health. Preclinical work in a mouse model of atopic dermatitis had suggested that R. mucosa strains collected from healthy skin can relieve disease symptoms. The new findings, published May 3 in JCI Insight, support further evaluation of this potential new therapy.

Atopic dermatitis is an inflammatory ski...

Read More

Liver Fix Thyself: How Some Liver Cells Switch Identities to Build Missing Plumbing

Mice that mimic Alagille syndrome are born without the branches of the biliary tree (A), but show a near-normal appearing biliary system at adult age (B). To build the missing branches, liver cells switch identity and form tubes, shown in green, that connect to the trunk of the biliary tree, shown in blue (C). The images are part of a study about liver regeneration published in Nature by scientists at Cincinnati Children's and the University of California San Francisco. Credit: Cincinnati Children's

Mice that mimic Alagille syndrome are born without the branches of the biliary tree (A), but show a near-normal appearing biliary system at adult age (B). To build the missing branches, liver cells switch identity and form tubes, shown in green, that connect to the trunk of the biliary tree, shown in blue (C). The images are part of a study about liver regeneration published in Nature by scientists at Cincinnati Children’s and the University of California San Francisco. Credit: Cincinnati Children’s

By studying a rare liver disease called Alagille syndrome, scientists from Cincinnati Children’s and the University of California San Francisco (UCSF) have discovered the mechanism behind an unusual form of tissue regeneration that may someday reduce the need for expensive and difficult-to-obta...

Read More

Double-bridged Peptides Bind any Disease Target

A model of a double-bridged peptide (the peptide in light blue, the two bridges in yellow). The background of the figures shows many examples of skeletons (also named 'scaffolds' or 'backbones') of double-bridged peptides. Credit: C. Heinis/EPFL

A model of a double-bridged peptide (the peptide in light blue, the two bridges in yellow). The background of the figures shows many examples of skeletons (also named ‘scaffolds’ or ‘backbones’) of double-bridged peptides. Credit: C. Heinis/EPFL

Scientists have developed a new type of ‘double-bridged peptide’ that can be tailored to bind tightly to disease targets of interest. The peptides’ highly efficient binding, combined with their small size and high stability make them ideal for drug therapies...

Read More